🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus on an empty stomach is ruining my mornings — anyone have experience? Page 2

Rybelsus on an empty stomach is ruining my mornings — anyone have experience?

PharmacoVig_BOS Mon, Jul 22, 2024 at 1:04 PM 41 replies 2,693 viewsPage 2 of 9
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Jul 22, 2024 at 7:36 PM#6
Dr.RenalNash said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Last edited: Jul 22, 2024 at 8:36 PM
50 20Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 47 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jul 22, 2024 at 10:10 PM#7

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

49 19tom_AK, josh_phd_bmore, roxy_nash and 46 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Jul 23, 2024 at 12:44 AM#8
JennaRN said:
I do not accept that the fasting window is a minor inconvenience.

Coming at JennaRN’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Jul 23, 2024 at 2:44 AM
48 18HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Jul 23, 2024 at 3:18 AM#9

One thing that is still open after hans_munich’s answer:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Jul 23, 2024 at 9:18 AM
47 17HPLC_Greg, LibrarianMeg, bri_stats and 44 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jul 23, 2024 at 3:35 PM#10

Closing the loop on my own question.

Update — I went back to the injectable. Not because the tablet did not work, but because the fasting window and my mornings were never going to agree.

27 2LabKate, kate.chem, DataDave and 24 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register